trending Market Intelligence /marketintelligence/en/news-insights/trending/vigzodxt44alkouynp3e2w2 content esgSubNav
In This List

Humanigen adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Humanigen adds board member

Rainer Boehm will join the Humanigen Inc. board Feb. 12.

Boehm was previously chief commercial and medical affairs officer for Novartis Pharma AG, a Novartis AG unit.

Brisbane, Calif.-based Humanigen is a biotechnology company developing treatments for cancer.